Immediate Impact
1 by Nobel laureates 3 from Science/Nature 64 standout
Citing Papers
Deciphering breast cancer: from biology to the clinic
2023 Standout
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
Works of Jutta Steinseifer being referenced
Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.
2022
LBA14 Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) + palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jutta Steinseifer | 967 | 476 | 518 | 15 | 1.4k | |
| Linnea Chap | 1033 | 359 | 651 | 28 | 1.7k | |
| Brian J. Yoder | 659 | 315 | 455 | 22 | 1.4k | |
| D. Frye | 1452 | 394 | 298 | 20 | 1.9k | |
| Amy P. Sing | 1332 | 420 | 494 | 32 | 1.9k | |
| P Hurteloup | 958 | 419 | 282 | 31 | 1.9k | |
| Mohammad Jahanzeb | 938 | 531 | 346 | 32 | 1.5k | |
| Blair Marshall | 624 | 504 | 786 | 10 | 1.7k | |
| Mariantonietta Colozza | 999 | 298 | 347 | 36 | 1.4k | |
| Grazyna Liebérman | 1057 | 393 | 526 | 9 | 1.7k | |
| Thomas E. Seay | 1708 | 492 | 253 | 20 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...